RxDoctor Payments Data

Christian Gonzalez

Family · Houston, TXNPI 1376200758

Payments from drug & device makers

$1,014in general payments, 2019–2025

Across 65 payments — averaging $15.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$298
  • Sanofi-aventis U.S. LLC$152
  • Takeda Pharmaceuticals U.S.A., Inc.$85
  • Biohaven Pharmaceutical Holding Company Ltd.$68
  • AbbVie$54
  • Antares Pharma, Inc.$47
  • plus $309 from 14 others

What the payments were for

  • Food & beverage$1,014100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,014 in reported general payments places this provider in the 65th percentile of 15,456 family providers in Texas.

See all family providers in Texas

Medicare billing

Part B allowed, 2024
$20,666
Medicare patients
224
Services billed
264

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin Hcl38$83

Paid to pharmacies, not to this prescriber.

Other family in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →